Latest Disruptive Pharma News & Updates

See the latest news and media coverage for Disruptive Pharma. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Disruptive Pharma

Pharmaceutical technology company

guardtherapeutics.com
Headquarters
Stockholm, Sweden
Company type
Public company
Number of employees
5–10
Industry
Pharmaceuticals

Last updated

Latest news about Disruptive Pharma

In short: Guard Therapeutics completed a reverse takeover of Disruptive Pharma and rebranded after its lead drug candidate failed Phase 2b trials.

Company announcements

Disruptive Pharma

Guard Therapeutics approves acquisition of Disruptive Pharma

The general meeting decided on new articles of association, authorizations for new share issues and a new board. Disruptive Pharma is valued at SEK 61 million.

Unlock all announcements with a

Media coverage

Dagens industri

Guard Therapeutics gets to stay on NGM

The biotech company Guard Therapeutics has received conditional approval from Nasdaq Stockholm for continued listing of the company's shares on Nasdaq First North Growth Market, within the framework of the planned reverse acquisition of Disruptive Pharma.

The Wall Street Journal

Guard Therapeutics International AB

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least...

Dagens industri

Reduced losses for Guard Therapeutics

Guard Therapeutics reports a result of minus 6.4 million kronor (minus 34.2) for the first quarter of 2026. Liquid funds at the end of...

Unlock all articles with a

Never miss news about Disruptive Pharma

Track Disruptive Pharma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.